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Antigenic variation in Plasmodium falciparum <p>A microarray analysis of <it>Plasmodium falciparum </it>selected to express different <it>var </it>genes suggests that antisense  transcripts are not responsible for the transcriptional silencing of non-expressed <it>var </it>genes.</p>
Abstract
Background: Plasmodium falciparum, the causative agent of the most severe form of malaria,
undergoes antigenic variation through successive presentation of a family of antigens on the surface
of parasitized erythrocytes. These antigens, known as Plasmodium falciparum erythrocyte
membrane protein 1 (PfEMP1) proteins, are subject to a mutually exclusive expression system, and
are encoded by the multigene var family. The mechanism whereby inactive var genes are silenced is
poorly understood. To investigate transcriptional features of this mechanism, we conducted a
microarray analysis of parasites that were selected to express different var genes by adhesion to
chondroitin sulfate A (CSA) or CD36.
Results: In addition to oligonucleotides for all predicted protein-coding genes, oligonucleotide
probes specific to each known var gene of the FCR3 background were designed and added to the
microarray, as well as tiled sense and antisense probes for a subset of var genes. In parasites
selected for adhesion to CSA, one full-length var gene (var2csa) was strongly upregulated, as were
sense RNA molecules emanating from the 3' end of a limited subset of other var genes. No global
relationship between sense and antisense production of var genes was observed, but notably, some
var genes had coincident high levels of both antisense and sense transcript.
Conclusion:  Mutually exclusive expression of PfEMP1 proteins results from transcriptional
silencing of non-expressed var genes. The distribution of steady-state sense and antisense RNA at
var loci are not consistent with a silencing mechanism based on antisense silencing of inactive var
genes. Silencing of var loci is also associated with altered regulation of genes distal to var loci.
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Background
Plasmodium falciparum is a parasite belonging to the phy-
lum apicomplexa, a group characterized by intracellular para-
sitism. A striking feature of apicomplexans' intracellular
lifestyle is their ability to modify host cells though export of
macromolecules.  P. falciparum parasitizes erythrocytes,
which it proceeds to alter via the secretion of a large number
of proteins. Much of this protein content is represented by the
Plasmodium falciparum erythrocyte membrane protein 1
(PfEMP1) molecules, ligands that span the erythrocyte mem-
brane and mediate cytoadhesion to human receptors exposed
to circulating parasites. PfEMP1 proteins are encoded by var
genes, and field isolates possess approximately 60-70 distinct
var genes. Each var gene consists of a large variable 5' exon
(around 4-9 kb in length), and a smaller, more conserved 3'
exon (around 1 kb in length) that encodes the intracellular
portion of the PfEMP1 protein. Individual parasites do not
express all PfEMP1 isoforms simultaneously, but rather
change from one var to another successively. The adaptive
pressure that selects such behavior is controversial, but plau-
sible hypotheses include avoidance of host antibody
response, and changes in cytoadherence ligand in response to
tissue environment.
Switching of transcription from one var gene to another does
not require genetic rearrangements [1,2] (unlike antigenic
variation in Trypanosoma brucei), but is instead associated
with epigenetic changes [3-5]. Parasites can change from
expressing one PfEMP1 molecule to another both in vivo and
in vitro. The rate at which parasites switch away from their
parental phenotype is difficult to measure, and different
methods have resulted in estimates varying from less than 1%
per generation in vitro [6], to more than 16% per generation
in vivo [7].
The switching of active var genes in vitro means that cloned
parasites expressing individual var genes will eventually drift
in the absence of immune pressure to heterogeneous popula-
tions. This makes it difficult to assess how many var genes are
being expressed in individual parasites. However, parasites
selected for binding to different host receptors express dis-
tinct var genes and such populations have previously been
described to transcribe single dominant var genes [2]. Never-
theless many contentious questions remain about how var
genes are transcriptionally regulated. Some studies have sug-
gested that mutually exclusive expression is developmentally
controlled, with a number of var genes being transcribed in
ring-stage parasites, but only a single var transcribed in the
later trophozoite stage [2,8]. Other studies suggest that tran-
scription is initiated at a number of var loci, but that only a
single var gene produces complete transcripts [9]. Another
puzzling phenomenon is the so-called sterile transcripts that
are apparently produced from the 3' exon of many var genes
[10].
Analysis of the var introns shows that they contain a pro-
moter that is responsible for the sterile transcripts. The same
cryptic promoter was also shown to be bi-directionally func-
tional in reporter assays [11], raising the intriguing prospect
that antisense transcripts may play a role in var regulation.
Antisense transcription has been suggested as a general con-
trol mechanism for Plasmodium transcription [12-14], with a
global transcription profile indicating an inverse correlation
between abundance of sense and the ratio of sense-to-anti-
sense for many loci. Additionally, artificially introduced anti-
sense molecules have been used to specifically downregulate
some genes in P. falciparum [15-17]. Widespread antisense
transcripts are also believed to be involved in the modulation
of gene expression in humans [18], rice [19], and Arabidopsis
[20]. Although antisense is commonly seen as a means of
downregulating expression of the protein-coding strand, sev-
eral global transcriptional studies indicate some sense and
antisense RNAs are co-regulated, with transcription of both
strands up- or downregulated in certain conditions or tissues
[21,22].
To address these important outstanding questions concern-
ing regulation of var genes we constructed a customized oli-
gonucleotide array containing sense and antisense probes to
all known var genes of the P. falciparum FCR3 strain, in
addition to probes to all other predicted protein coding genes
of the sequenced 3D7 strain [23]. Individual parasites have
approximately 60 var genes, and of these, 36 have been iden-
tified so far in FCR3. For a subset of eight var genes, we made
tiled probes against both strands, spanning from the 5'UTR to
the 3'UTR. Parasites were panned on either CD36 or chon-
droitin sulfate A (CSA) to select for parasites expressing dis-
tinct var genes, then compared at three points through the
asexual intraerythrocytic life cycle. We hypothesized that
upregulation of a var  gene would be accompanied by
decreased abundance of complementary antisense, while
downregulated  var  genes would be associated with an
increase in corresponding antisense RNA. Instead, we found
that no consistent positive or negative correlation existed
between abundance of sense and antisense transcripts. Nota-
bly, the very strong upregulation of var2csa gene (Genbank:
AY372123) in CSA-selected parasites was accompanied with
substantially increased abundance of antisense RNA
throughout the same gene. These data indicate that antisense
RNAs do not control antigenic variation in Plasmodium. We
failed to find any evidence for var transcripts that included
only the 5' end, and we also show that 3' sterile transcripts are
limited to a subset of var genes.
Parasite adhesion phenotypes also correlate with some spe-
cific patterns of physiopathology so other non-var  genes
upregulated in association with specific binding types are of
interest. We detected several genes that are differentially
transcribed between CSA and CD36 parasites, including
mature parasite-infected erythrocyte surface antigen (MESA
- known to bind to the erythrocyte membrane cytoskeleton)http://genomebiology.com/2005/6/11/R93 Genome Biology 2005,     Volume 6, Issue 11, Article R93       Ralph et al. R93.3
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and other proteins predicted to be exported to the infected
erythrocyte.
Results and discussion
Transcriptional changes in var genes
Arrays containing specific var  gene probes for the FCR3
strain allowed us to assay steady-state RNA changes between
CSA-panned and CD36-panned parasites. Total RNA was
harvested from three time points through the parasite life
cycle, at 12 hours, 24 hours and 36 hours post invasion. Para-
sites from these time points are referred to as ring, tropho-
zoites and schizont stage parasites, respectively. Previous
analyses have shown that the peak of var transcription is in
ring stages [24,25] and this was confirmed by our analysis,
with highest total var transcripts present in ring stages (Fig-
ure 1) for both FCR3-CSA and FCR3-CD36. A comparison of
the two populations revealed that several var  genes are
expressed in the FCR3-CD36 population, while only one
dominant var, known as var2csa (or PFL0030c) is apparent
in the FCR3-CSA population. Multiple probes from this gene
detected transcripts at an abundance 150 to 200-fold higher
in FCR3-CSA than in FCR3-CD36 parasites (Figures 1 and 2).
This could reflect the almost total absence of var2csa tran-
scripts in FCR3-CD36 parasites. Peak transcript abundance
for this gene was in ring stages, with the fold-difference
between populations falling markedly in trophozoite (60 to
80-fold) (Figure 2) and schizont parasites (6 to 10-fold) (Fig-
ure 2). Only hybridization ratios and not levels of hybridiza-
tion are appropriate to consider when interpreting results
obtained with this type of glass spotted microarrays. How-
ever, the absolute values obtained for each RNA population
(we will refer to these as 'apparent absolute transcript levels'
or AATLs), also strongly suggest that peak transcript abun-
dance for this gene was in ring stages. Considering all var and
non-var  genes,  var2csa  was the most highly upregulated
gene found in FCR-CSA relative to FCR3-CD36 and had one
of the highest AATLs detected in these parasites (Figure 1).
These data are consistent with previous reports that find a
correlation between CSA binding and expression of var2csa
in different strains [26-28]. Northern analysis of FCR3-CSA
and FCR3-CD36 parasites prepared in our laboratory also
shows a very high expression of var2csa in CSA binding par-
asites and none in CD36-binding parasites [29]. Cross-reac-
tive probes directed against var exon 2, which detect most
(but not all) var genes detect no other var transcripts in CSA-
binding parasites [29]. Additionally, FCR3 parasites with the
var2csa gene disrupted can no longer bind to CSA. Although
our array covers all currently known var genes for the FCR3
strain, not every var gene has been sequenced. We therefore
cannot exclude that another unknown var gene is involved in
CSA binding, although evidence from transcription, pro-
teomic, serological and biochemical studies now indicates
that upregulation of var2csa  is central to CSA binding
[26,27].
A dominant var gene is upregulated in CSA binding parasites Figure 1
A dominant var gene is upregulated in CSA binding parasites. Plots of log2 
ratio of expression (M) against average log intensity (A) for ring, 
trophozoite and schizont stages for CSA versus CD36 panned parasites. 
Only statistically differential data giving a Bonferroni corrected p value 
(alpha = 0.05) have been displayed. This graph excludes probes 
corresponding to antisense transcripts and oligos to 3D7 var genes (whose 
orthologs in FCR3 diverge in sequence). Biological replicates were pooled. 
The plots reveal a single dominant var transcript (var2csa-marked in 
orange) that is much more abundant in CSA than in CD36-panned 
parasites at all life stages. Green dots represent all other oligos 
corresponding to FCR3 var genes. Several var genes are over-represented 
in CD36 as compared with CSA-panned parasites. Both log2 ratios of 
expression and apparent average intensities for var genes decrease 
through the life cycle.
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In addition to the major var2csa transcript, the microarray
analysis detected a less pronounced upregulation of a second
full-length var transcript in the CSA-binding population - the
A4-tres gene. The probes corresponding to this open reading
frame (ORF) indicated a 5 to 9-fold upregulation of this gene
in FCR3-CSA parasites compared with FCR3-CD36, but the
AATL for this gene is still relatively low (Additional data file
1), and varA4-tres transcript is not detected in CSA-panned
parasites by Northern blot using cross-reactive var probes
[29]. The A4tres protein is unable to mediate CSA binding in
var2csa knockout parasites, so it is unclear whether A4tres
has a role in CSA binding.
Unlike CSA binding, multiple var genes are known to partic-
ipate in CD36 interactions [30]. It is therefore unsurprising
that several var  genes are upregulated in the FCR3-CD36
population (Figure 1, Additional data files 1 and 2). No var
gene in this population exhibits the same fold change or the
same AATL as the var2csa gene in FCR3-CSA. This suggests
that the FCR3-CD36 population is not homogenous, but
rather a heterogeneous mix of parasites each expressing one
of a select subset of var genes. The molecular basis for CD36
binding is relatively well understood, and the domains
responsible for the interaction have been identified in several
strains [31-33]. The upregulated var genes in FCR3-CD36
include domains that have been previously demonstrated to
encode CD36-binding PfEMP1 proteins (for example,
varFCR3S1.2) ,  a s  w e l l  a s  s e v e r a l poorly characterized var
genes (for example, var_clone_70, var_cDNA11).
The current paucity of panning systems for selecting mono-
morphic populations prevents us from determining if the
behavior of the var2csa-expressing parasites is representa-
tive of all var types. Both the characterization of additional
receptor-ligand interactions and the development of selecta-
ble markers in or adjacent to var genes should generate valu-
able tools to address this in the future.
Antisense RNAs
Global and specific transcriptional profiles of P. falciparum
indicate extensive transcription from the antisense strand of
many genes [12]. Nuclear run-on assays show that antisense
production is highly alpha-amanitin sensitive, implying a
dependence on RNA polymerase II activity [14]. As in some
other organisms, the distribution of Plasmodium antisense
transcripts suggests a role in regulation of sense strands, with
abundance of sense and antisense frequently inversely
related for given loci [13]. The availability of genes specifically
up- or downregulated at the same life stage, and in genetically
identical parasites, creates an ideal system to test the impor-
tance of antisense RNAs for Plasmodium gene expression. To
investigate this mechanism, we designed specific oligonucle-
otides probes for antisense RNAs derived from all known var
genes of the FCR3 strain. For eight of these genes we also
printed multiple oligonucleotide probes tiling the sense and
antisense strands of eight different var genes (see Additional
data file 1). These include var  genes strongly upregulated
(var2csa), weakly upregulated (varA4tres), downregulated
(varFCR3S1.2) or with no change (varITOR29, varITO4A4)
in FCR3-CSA relative to FCR3-CD36.
Our data reveal a pattern for var antisense transcripts that is
not consistent with direct antisense transcriptional inhibition
(Figure 3). For var loci with high upregulation of sense tran-
script, the corresponding antisense was sometimes downreg-
ulated and sometimes upregulated. Similarly,
downregulation of some sense transcripts was seen in con-
junction with downregulation of complementary antisense
but for other var genes was accompanied with upregulation
of antisense (Figure 3). It is noteworthy that for the most
highly upregulated sense transcripts (for example, the
var2csa gene in CSA panned parasites), strong upregulation
of antisense was also seen (Figure 2). The abundance of these
antisense molecules is comparable with that produced from
other genes known to have highly abundant antisense (for
example, MSP2 [34]) (Figure 2). For var loci, these antisense
RNA molecules were distributed throughout the gene,
although their apparent absolute abundance was much more
variable than that of the corresponding sense strand. For
example, sense probes throughout the var2csa gene detected
consistently strong upregulation throughout the ORF, while
antisense RNAs were highly upregulated at some positions in
the same gene and not at all in other positions (Figure 2). The
large changes in both apparent absolute abundance, and in
fold change for neighboring probes against antisense, sug-
gests that antisense RNAs may not be large molecules span-
ning the entire gene, but rather multiple short transcripts
initiating and terminating several times within several kb.
Consistent sense transcript and interspersed antisense transcript in var2csa gene Figure 2 (see following page)
Consistent sense transcript and interspersed antisense transcript in var2csa gene. Histograms showing apparent absolute abundance of both sense and 
antisense transcript at the var2csa locus in CD36 (grey) and CSA (white) panned parasites. Different columns show the apparent absolute abundance for 
oligonucleotides at individual positions along the whole var2csa gene. Left panels show probes corresponding to sense transcript, right panels show probes 
corresponding to antisense transcripts. Separate histograms show data for ring, trophozoite and schizont stages. Standard deviation is shown. No 
truncated 5' transcript of the var2csa gene is apparent in CD36 panned parasites, suggesting regulation is not controlled by premature termination of 
transcription. In ring stages, where var2csa transcript is most abundant in CSA parasites, apparent absolute abundance is also increased for antisense 
transcripts throughout the gene. Unlike sense transcription, apparent absolute abundance for all antisense transcripts varies greatly between adjacent 
probes, perhaps indicative of multiple short antisense transcripts initiating throughout the locus. Abundance of sense and antisense transcript in both 
populations is also shown for a non-var locus, msp2, for which high antisense transcription has previously been measured [34]. Both steady-state sense and 
antisense levels for the var2csa locus are comparable with those found at the msp2 locus.http://genomebiology.com/2005/6/11/R93 Genome Biology 2005,     Volume 6, Issue 11, Article R93       Ralph et al. R93.5
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Figure 2 (see legend on previous page)
var2csa - antisense
R
i
n
g
T
r
o
p
h
o
z
o
i
t
e
S
c
h
i
z
o
n
t
var2csa - sense
100
1,000
10,000
100,000
5' UTR
Exon1 part1
Exon1 part2
Exon1 part3
Exon1 part4
Exon1 part5
Exon1 part6
Exon1 part7
Exon1 last kb
Exon 2
msp2
100
1,000
10,000
100,000
5' UTR
Exon1 part1
Exon1 part2
Exon1 part3
Exon1 part4
Exon1 part5
Exon1 part6
Exon1 part7
Exon1 last kb
Exon 2
msp2
100
1,000
10,000
100,000
5' UTR
Exon1 part1
Exon1 part2
Exon1 part3
Exon1 part4
Exon1 part5
Exon1 part6
Exon1 part7
Exon1 last kb
Exon 2
msp2
100
1000
10,000
100,000
5' UTR
Exon1 part1
Exon1 part2
Exon1 part3
Exon1 part4
Exon1 part5
Exon1 part6
Exon1 part7
Exon1 last kb
Exon 2
msp2
100
1,000
10,000
100,000
5' UTR
Exon1 part1
Exon1 part2
Exon1 part3
Exon1 part4
Exon1 part5
Exon1 part6
Exon1 part7
Exon1 last kb
Exon 2
msp2
100
1,000
10,000
100,000
5' UTR
Exon1 part1
Exon1 part2
Exon1 part3
exon1 part4
Exon1 part5
Exon1 part6
Exon1 part7
Exon1 last kb
exon 2
msp2R93.6 Genome Biology 2005,     Volume 6, Issue 11, Article R93       Ralph et al. http://genomebiology.com/2005/6/11/R93
Genome Biology 2005, 6:R93
Although promoter elements in var  introns have been
described that appear to drive reverse strand transcription (at
least on plasmids) [11], the scattered production of antisense
RNA that we observe points to weak promoter-like activity
dispersed throughout the var  genes. Our failure to detect
antisense for the var loci that are silenced does not conclu-
sively prove that they cannot play a role in var silencing, but
the presence of abundant antisense molecules that coincide
with highly transcribed (and translated) mRNA molecules
strongly argues against their having a direct role in gene
silencing.
Both the interspersed distribution of antisense RNA mole-
cules and their coincident high abundance with a strongly
upregulated protein-coding gene are evocative of a non-spe-
cific induction that can correspond with activation of a var
gene. Our current understanding of var gene activation is that
var genes are activated through disassociation from silencing
molecules, subsequent local histone modification and
decondensation of the local chromatin environment [3-5].
Indeed this has been shown for the var2csa gene itself. Such
modifications make the DNA more accessible to initiation
factors and to RNA polymerase. This increased accessibility is
consistent with the concept of relaxed non-specific
transcription from both strands in the surrounding environ-
ment. We hypothesize that the production of antisense RNA,
at least in the case of var genes, is not a mechanism for silenc-
ing the protein coding strand, but is rather a consequence of
an open chromatin configuration and greater concentration
of transcription factors required for expression of the active
var gene (Figure 4). A similar explanation has been advanced
for some human loci, where sense and antisense RNAs are co-
ordinately regulated [22]. Long transcripts simultaneously
produced from both strands are physically implausible, as
one polymerase complex would displace the other. This is
consistent with our finding that antisense fragments appear
to be small, or alternatively, that sense and antisense are pro-
duced simultaneously but in different cells.
Full length or incomplete transcripts?
Various studies of var transcription have been able to detect
transcripts corresponding to multiple var genes from para-
site populations [2,8] or from single cells [35]. Most of these
No inverse correlation between sense and antisense ratio changes Figure 3
No inverse correlation between sense and antisense ratio changes. Scatter 
plots of log2 ratio of expression (M) (CSA-panned parasites over CD36-
panned) for antisense oligonucleotides against sense oligonucleotides for 
var genes. Data are shown for ring, trophozoites and schizont stages from 
biological replicate 1. Oligonucleotides corresponding to var2csa are 
represented by open triangles and the other var genes from the FCR3 
strain are displayed as black dots. Oligonucleotides with the highest log2 
ratio of expression in CSA- compared with CD36-panned parasites often 
correspond to those with the highest corresponding ratios for antisense 
abundance (upper right datapoints). Similarly, several sense transcripts 
apparently highly upregulated in CD36 correspond to upregulated 
antisense oligos at the same loci (lower left datapoints). These data are 
not consistent with a direct transcriptional silencing role for antisense 
transcription.
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A hypothetical model for antisense transcription from var loci Figure 4
A hypothetical model for antisense transcription from var loci. Sense and 
antisense RNA at several var loci appear to be coordinately regulated. This 
may result from the altered chromatin state of the encoding genomic 
DNA, which is differentially modified between silent and active var loci [3]. 
Silencing factors such as the SIR complex (indicated by blue spheres) bind 
to inactive var genes, maintaining the chromatin in a condensed state. In 
the absence of SIR, the active var assumes a relaxed chromatin 
conformation that makes the surrounding locus competent for 
transcription. While a stable transcription complex with appropriate 
assembly of elongation factors generates abundant sense mRNA of full 
length, transcription from the opposite strand initiates and quickly 
terminates to produce fragments of antisense. Simultaneous transcription 
of the same bases from opposite directions is unviable, but in a population, 
both transcription events may occur at the same time. A chromatin 
barrier located in the intron [11] may maintain the first exon in a silencing 
conformation while allowing relaxation of the second exon, leading to 
partial 3' transcripts from a subset of otherwise silenced var genes.http://genomebiology.com/2005/6/11/R93 Genome Biology 2005,     Volume 6, Issue 11, Article R93       Ralph et al. R93.7
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studies have used degenerate primers targeted to the con-
served DBL region found at the 5' of most var genes. These
results have led to the widespread understanding that tran-
scription initiates at many var  genes, but full-length var
genes are produced from only one or very few loci [9]. Unfor-
tunately the size of these molecules has never been thor-
oughly investigated and we find no data in the literature to
suggest that these RNA species are in fact prematurely trun-
cated. Indeed where RT-PCR has been used to assay tran-
scription of the 3' end of var genes (across the splice site)
multiple transcripts are still detected, even in adhesion-
restricted lines [36]. Certainly, sensitive RT-PCR amplifica-
tions do produce evidence of multiple var transcripts, but
these multiple transcripts are undetectable by Northern anal-
ysis. Our data do not support the existence of truncated 5'
transcripts resulting from multiple var loci, although it is
possible that some transcript exists below the limits of detec-
tion. Additionally, our experiments are unable to address
whether some transcripts from multiple loci might be pro-
duced but very quickly degraded. This is still a possible addi-
tional means of var regulation, although the only published
nuclear run-on experiments (which can still only partially
address this issue) found no evidence of 'leaky' transcription
from multiple var loci [2].
Although there are no quantitative data available regarding
the existence of truncated transcripts originating at the 5' end
of var genes, Northern blots using a probe from the 3' exon do
consistently detect abundant RNA, often referred to as 'sterile
transcript'. These probes cross react with the large pf60 fam-
ily of genes and pseudogenes, which are transcribed in late-
stage parasites and are approximately 3 kb in length. Other
transcripts of around the same size appear to emanate from
var introns themselves [10], though it is unknown at which
stage these intron-derived fragments are produced. These
intron-derived fragments, and perhaps pf60 transcripts too,
may be involved in var silencing. Assays conducted with luci-
ferase reporter driven by a var promoter indicated that the
presence of a flanking var intron is required for proper silenc-
ing [11]. Mutations perturbing the promoter activity within
this intronic sequence also disrupt silencing, indicating the
sterile transcripts may themselves play a role in var silencing.
We investigated the distribution of these var intron-derived
transcripts using var genes for which we had probes for exon
1 and exon 2 transcripts. Our data show that transcripts do
originate from the var introns, but only for a subset of var
genes. For several var  genes in the FCR3-CSA parasites,
probes throughout exon 1 indicate the gene is silenced, but
exon 2 is strongly upregulated. For example, exon 1 of
varFCR3S1.2 is downregulated 5 to 25-fold in FCR3-CSA par-
asites, but exon 2 probes show a 10 to 25-fold upregulation.
For other silenced var genes (for example, var2csa in FCR3-
CD36 parasites or varFCR3 T11-1 in FCR3-CSA parasites) no
sterile transcript is apparent in the same parasites, nor is it
upregulated at any of the life-stages sampled. For some loci,
intron-derived transcript was most abundant in ring
transcripts, while at other loci exon 2 transcript was more
abundant in later-stage parasites (Additional data file 1). The
confusing overlap and cross hybridization of the var exon 2
transcript with pf60 transcript makes it difficult to clarify the
relative abundance of either RNA species by Northern blot.
The absence of sterile transcripts corresponding to some
silenced genes indicates that continuous presence of sterile
transcript is not an absolute requirement for var silencing.
Calderwood and colleagues have speculated that the
promoter for sterile transcripts may participate in silencing
by acting as a buffer for chromatin spreading [11]. Alterna-
tively, sterile transcripts may flag complementary genomic
regions as targets for chromatin condensation. If either of
these possibilities is true, the promoter activity might be
required to initiate the silencing chromatin state, but not to
maintain it. Our discovery that transcripts are produced from
the introns of some silenced var genes but not others requires
a rethinking of the involvement of sterile transcript in
silencing.
The var1csa gene
One  var  g e n e  t h a t  h a s  b e e n  i m p l icated in CSA adhesion
through serological and binding assays is the var1csa gene
[37-39]. Consistent with recent reports [35,40], we find that
this gene does not appear to be upregulated at a transcrip-
tional level in CSA-binding parasites. A previous study indi-
cated that this gene is transcribed throughout the erythrocytic
life cycle, apparently irrespective of adherence phenotypes
[40]. This pattern is confirmed by our data, which show
apparently continuous low-level expression of the var1csa
gene in both CSA- and CD36-panned populations (Additional
data file 1). Our data do not exclude a role for the Var1CSA
protein in CSA binding, but they do suggest that the tran-
scription status of var1csa is not in itself indicative of CSA
binding.
Steady-state RNA changes in non-var genes
Several non-var genes encoding parasite proteins predicted
to be exported to the infected erythrocyte [41] are differen-
tially abundant in our analysis (Additional data file 1). The
most dramatic difference is seen for the pfe0040c  gene,
encoding the mature parasite-infected erythrocyte surface
antigen (MESA - also known as PfEMP2). Three independent
probes consistently registered 16-24 times greater abundance
of this transcript in ring and trophozoite stages of the FCR3-
CD36 parasites compared with FCR3-CSA (Figure 1). It is
worth noting that MESA seems to be negatively co-regulated
with var2csa (mean of Pearson R = -0.87 for a var2csa ran-
dom sample of 6 of 30 values for each time point with the 6
mesa values available with 10,000 iterations). This was con-
firmed by Western blot (Figure 5a) and immunofluorescence
(Figure 5b) with a monoclonal antibody specific for the MESA
protein. Substantially more MESA is present in FCR3-CD36
t h a n  i n  F C R 3 - C S A  p a r a s i t e s .  T h e  l o c a l i z a t i o n  o f  M E S A  i s
unchanged between the two parasite types, with immunoflu-R93.8 Genome Biology 2005,     Volume 6, Issue 11, Article R93       Ralph et al. http://genomebiology.com/2005/6/11/R93
Genome Biology 2005, 6:R93
orescence showing a distribution at the erythrocyte periph-
ery. In both populations, over 95% of mature parasites are
positive for MESA by indirect immunofluorescence assay, so
differences in transcript abundance are not due to a gene
deletion in FCR3-CSA (as can sometimes happen with subte-
lomerically-located MESA). MESA is known to bind to the
erythrocyte membrane skeletal protein 4.1 [42], and is
thought to alter host cell membrane stability. However, eryth-
rocytes infected by mutant parasites lacking MESA are able to
adhere normally to CD36-presenting cells [43,44], indicating
MESA is not required for cytoadhesion, at least in vitro. This
does not exclude a role in vivo and the observation of major
differences in levels of MESA expression between parasites
expressing PfEMP1 with different adhesive properties is
intriguing.
Transcripts representing several hypothetical proteins are
differentially abundant in FCR3-CSA and FCR3-CD36, and
their localization and function deserve further attention. Sev-
eral possess targeting motifs predicted to direct their export
out of the parasite and into the red blood cell (RBC) [41]
(notable examples include PFC1080c, PFA0615w and
PFD0080c) (Additional data file 1). Other annotated genes
that are differentially regulated include the exported RBC
protein GARP, and MAEBL, a predicted invasion ligand. The
differential expression of genes not involved in cytoadhesion
suggests that receptor use may actually trigger other changes
that might be more involved in adaptations to tissue environ-
ment or local pH. Our data do not reveal any obvious candi-
dates for signaling molecules involved in detection of or
reaction to the parasites' external environment.
Conclusion
The past three years have seen an increasing number of global
transcriptional analyses of P. falciparum. Experiments have
compared transcriptional changes between the vertebrate life
stages [23,45], between genetically distinct strains [46,47],
and in response to drug treatment [48] or glucose deprivation
[49]. Despite high-quality, reproducible data demonstrating
that a very high proportion of genes are rigidly and specifi-
cally regulated, recent reviews highlight our scant under-
standing of transcriptional control in Plasmodium [50,51].
Very few transcription factors have been identified, and
genetic regulatory elements are not well described. This defi-
cit has suggested to some that gene regulation in Plasmodium
is post-transcriptionally controlled, perhaps by antisense-
mediated repression [13].
Our analysis of parasite cytoadhesion shows that differences
in receptor use are associated with limited specific transcrip-
tional differences for both var and non-var genes. We find no
changes in known transcription factors that associate with the
observed differences. This is consistent with previous studies,
which suggest that var transcription is regulated by histone
modification and chromatin condensation. Silencing of var
genes was not associated with increased antisense production
at silenced loci, but rather, antisense abundance was in some
cases coincident with high sense strand transcription. This
indicates that var regulation is not mediated by antisense
inhibition. Instead, antisense transcription may be a product
of relaxation in the local chromatin structure (as reported in
[3] and [5]), accompanied by loci moving to pro-transcription
nuclear zones that may allow promiscuous conditions for
transcription [3]. High-resolution microarrays offer very
promising avenues for the investigation of such interactions
between chromatin-mediated events and transcriptional reg-
ulation. Future studies will reveal DNA regions that are con-
trolled by chromatin remodeling factors by superimposing
array transcriptional information over data from 'ChIP-on-
chip' analyses that use microarrays of immunoprecipitated
chromatin to map specific chromatin features to the genome.
Materials and methods
Parasite culture
FCR3 parasites were cultured using modifications to the
method described by Trager and Jensen [52]. Parasites were
grown in a gas environment of 5% CO2, 1% O2 and 94% N2.
MESA overexpression in CD36 parasites Figure 5
MESA overexpression in CD36 parasites. (a) Western blot of non-
synchronized parasites from FCR3-CD36 and FCR3-CSA parasites. 
PfHsp70 protein is included as a loading control. A monoclonal antibody 
(Pf12.8B7.4) against MESA [60] detects approximately 2-4 times more 
protein in CD36 compared with CSA panned parasites. (b) 
Immunofluorescence for MESA protein in FCR3-CD36 and FCR3-CSA 
parasites. The 488-labeled secondary shows that MESA is considerably 
more abundant in CD36-compared with CSA-panned parasites. The 
intracellular distribution of MESA is the same in both parasite populations 
- with most labeling localizing to the periphery of infected erythrocytes.
FCR3-CD36
FCR3-CSA (a)
(b)
MESA
PfHSP70
10µm
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Media was supplemented with 5% v/v human serum and 5%
v/v Albumax II (Invitrogen SARL Cergy Pontoise, France).
Panning of infected erythrocytes
P. falciparum strain FCR3 was panned on endothelial cells
expressing either CSA (SBEC-17 line) or CD36 (SBEC-CS2
line) as described previously [2]. The resulting populations
are hereafter referred to as FCR-CSA and FCR-CD36, respec-
tively. Panning was repeated twice more, and parasites were
tested for their ability to bind purified CSA (Sigma) or soluble
recombinant CD36 (Affymax Research Institute) immobi-
lized with monoclonal antibody 179 (Affymax Research Insti-
tute). After panning, parasites were expanded for 4-6
generations to generate sufficient quantities for analysis.
Mature stages were eliminated using 0.3 M alanine in 10 mM
HEPES [53]. Parasites were allowed to reinvade and were
synchronized with 0.3 M alanine twice with an interval of
eight hours to obtain tightly synchronous parasites. Parasites
were allowed to reinvade once again, and were harvested at 12
hours, 24 hours and 36 hours post invasion. FCR3-CD36 par-
asites appeared to have a slight but consistently shorter life
cycle than the FCR3-CSA parasites. For this reason, the sch-
izont stage comparison was slightly asynchronous (2-4 h)
with the CD36 parasites slightly more mature than the CSA.
Subsets of parasites were assayed for their adhesion to CD36
and CSA immediately before and after each harvesting to
confirm specificity of binding. Non-specific binding was at
the level of the bovine serum albumin negative control for all
populations.
Total RNA preparation
Infected erythrocytes were washed in PBS, permeabilized
with 0.05% saponin in PBS, washed three times in PBS, and
lysed in 10 pellet volumes of Trizol (Gibco) before freezing at
-80°C. Total RNA was prepared from thawed samples as per
the manufacturer's instructions. RNA quality was assessed
with an Agilent 2100 Bioanalyser (Additional data file 4).
Oligonucleotides
The Malaria Oligo Set (Qiagen-Operon), designed by DeRisi
[54], containing 7,393 optimized 70-mers corresponding to
4,644 annotated genes and to putative ORFs, was completed
with 1,477 new oligos we designed using ArrayOligoSelector
[54,55]. These new oligonucleotides corresponded to anno-
tated genes in PlasmoDB that lacked oligos in the set, and
also, sense and antisense probes to all known var genes of the
P. falciparum FCR3 strain; for a subset of var genes, tiled
probes were designed against both strands, spanning from
the 5'UTR to the 3'UTR.
Microarray spotting, cDNA target labeling 
hybridization and scanning
Oligonucleotides were resuspended in 3X SSC at 40 µM and
printed onto UltraGAPS glass slides (Corning) using a Chip-
writer Pro Virtek arrayer (Biorad). After printing, arrays were
treated as per the instructions of the slide manufacturer
(Corning).
RNA samples (5 µg) were indirectly labeled using Atlas Pow-
erScript Fluorescent Labeling kit (Clontech) with a mixture of
random hexamer (pdN6), according to the conditions recom-
mended by the manufacturer, with the following modifica-
tions: after reverse-transcription, RNA was digested with
RNAse H for 45 minutes at 37°C. cDNAs were coupled with
cyanines using Cy3 Mono-Reactive Dye or Cy5 Mono-Reac-
tive Dye (Amersham Bioscience). Fluorescent cDNA was then
purified with QIAquick PCR Purification Kit (Qiagen). Target
quality and concentration were determined by spectroscopy
at 260 nm, 280 nm and 550 nm (Cy3) or 650 nm (Cy5). Cy3
and Cy5 target quantities were normalized at 250 pmol,
mixed and thereafter concentrated by Microcon YM-30 (Mil-
lipore). Sample volumes were adjusted to 50 µl in 5X SSC, 0.1
mg/ml fragmented Salmon sperm DNA (Sigma), 30% forma-
mide and 0.1% SDS.
Microarrays were pre-hybridized in 5X SSC, 1 mg/ml BSA
and 0.1% SDS for 1 hour at 42°C, and then washed by immer-
sion in dH2O for 1 minute, followed by isopropanol and dried
by centrifugation for 2 minutes at 1,500 rpm. Fluorescent tar-
gets were denatured 3 minutes at 95°C, incubated at RT for 5
minutes prior to hybridization and briefly spun, then loaded
onto the array under a LifterSlip (Erie Scientific) and incu-
bated in a humid chamber (Telechem) for 16-18 hours at
42°C. After hybridization, slides were washed twice in 2X SSC
and 0.1% SDS at 42°C for 5 minutes, twice in 0.1X SSC and
0.1% SDS at RT for 10 minutes and four times in 0.1X SSC for
1 minute at RT, and then dried by centrifugation at 1,500 rpm
for 2 minutes. Arrays were scanned with an Axon 4000a scan-
ner with fixed PMT (PMT = 550 for Cy3 and 650 for Cy5).
Data were acquired and analyzed by Genepix Pro 5.0 (Axon
Instrument).
Statistical analysis
For each developmental stage, dye swaps with two technical
replicates and two biological replicates were performed to
compensate dye effect and to assess technical and biological
reproducibility, leading to eight hybridized slides. Each bio-
logical replicate was analyzed separately using R functions
(The R project) and Bioconductor package [56]. After loga-
rithm transformation of ratio of the median of the intensities
(without background subtraction) in the two channels, an
intensity-dependent normalization was applied to each slide.
A Loess curve (locally weighted least squares regression) was
fitted to (1/2)log2(Cy5×Cy3) versus log2(Cy5/Cy3) plot (MA
plot), where 40% of the data was used to calculate the Loess
fit at each point [57]. This curve was used to adjust log2(ratio)
for each spot. Empty and flagged spots were excluded from
the analysis. A paired Student t test was used to assess differ-
entially expressed spots. After exclusion of the values pre-
senting too much or not enough variation, the common
variance was used for all genes to improve the robustness ofR93.10 Genome Biology 2005,     Volume 6, Issue 11, Article R93       Ralph et al. http://genomebiology.com/2005/6/11/R93
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the test. The raw p values were then corrected using the Bon-
ferroni method with a type I error of 0.05. All log2 ratios are
presented as CSA-panned condition over CD36-panned
condition. Our data have been submitted to the publicly avail-
able ArrayExpress database [58].
Immunofluorescence
FCR3-CSA and -CD36 P. falciparum-infected erythrocytes
were taken from asynchronous cultures and processed for
indirect immunofluorescence assay as previously described
[59]. Slides of air-dried blood films were incubated with the
MAb Pf12.8B7.4 [60] for 30 minutes at RT, washed and incu-
bated with Alexa-labeled F(ab') fragment of goat anti-mouse
IgG (Molecular Probes) in the same conditions. The nuclei
were counterstained with 10 ng/µl DAPI (Molecular Probes).
The slides were mounted in 50% glycerol in PBS containing
0.1% p-phenylenediamine (Sigma) as anti-fading. Mouse
Mab89 anti-PfHRPI (or PfKAHRP) [61] and guinea pig anti-
ATS domain from PfEMP1 (D Mattei, unpublished data) were
used as positive controls. Labeled erythrocytes were visual-
ized under UV light in an E800 Nikon Microscope. Images
were acquired under identical exposure conditions and proc-
essed with Adobe Photoshop 7.0.
Western blot
Total parasite SDS extracts were subjected to 7.5% SDS-
PAGE and were transferred onto nitrocellulose. Membranes
were incubated with MAb Pf12.8B7.4 [60] and processed for
chemiluminescence detection according to the manufacturer
(SuperSignal West Pico Chemiluminescent Substrate,
Pierce). Mab1C11 anti-PfHsp70 was used as control [62]. Pre-
stained molecular weight markers were obtained from
BioRad.
Additional data files
The following additional data are included with the online
version of this article: a table showing normalized array data
for all FCR3 and 3D7 sense and antisense oligos included in
the analysis, with data from 12 hours (ring stage), 24 hours
(trophozoite stage) and 36 hours (early schizont stage) time-
points. The table shows data from biological and dye repeats,
in addition to dye swap replicates (Additional data file 1); a
table with a subset of the microarray expression data showing
normalized array data for the oligos corresponding to sense
and antisense strands of var  genes from 3D7 and FCR3
(Additional data file 2); histograms showing apparent abso-
lute abundance of the varA4tres and varFCR3s1.2 transcript
in CD36 (grey) and CSA (white) panned parasites. Different
columns show the apparent absolute abundance for oligonu-
cleotides at individual positions along the genes. Left panels
show probes corresponding to sense transcript, right panels
show probes corresponding to antisense transcripts. Separate
histograms show data for ring, trophozoite and schizont
stages. Standard deviation is shown. The antisense patterns
for both genes show a pattern that is inconsistent with a var
silencing role for antisense, with antisense just as high for all
life stages in the active population as in the silenced popula-
tions. As in other genes, adjacent probes for antisense are
much more variable than in the corresponding sense strand,
suggesting antisense transcripts are small and interspersed
(Additional data file 3); Agilent 2100 bioanalyzer analysis of
total RNA used for microarrays. Virtual gel images and elec-
trophereograms are shown for all timepoints for both treat-
ments and replicates (Additional data file 4).
Additional data File 1 A table showing normalized array data for all FCR3 and 3D7 sense  and antisense oligos included in the analysis A table showing normalized array data for all FCR3 and 3D7 sense  and antisense oligos included in the analysis, with data from 12  hours (ring stage), 24 hours (trophozoite stage) and 36 hours (early  schizont stage) timepoints. The table shows data from biological  and dye repeats, in addition to dye swap replicates Click here for file Additional data File 2 A table with a subset of the microarray expression data showing  normalized array data for the oligos corresponding to sense and  antisense strands of var genes from 3D7 and FCR3 A table with a subset of the microarray expression data showing  normalized array data for the oligos corresponding to sense and  antisense strands of var genes from 3D7 and FCR3 Click here for file Additional data File 3 Histograms showing apparent absolute abundance of the  varA4tres and varFCR3s1.2 transcript in CD36 (grey) and CSA  (white) panned parasites Histograms showing apparent absolute abundance of the  varA4tres and varFCR3s1.2 transcript in CD36 (grey) and CSA  (white) panned parasites. Different columns show the apparent  absolute abundance for oligonucleotides at individual positions  along the genes. Left panels show probes corresponding to sense  transcript, right panels show probes corresponding to antisense  transcripts. Separate histograms show data for ring, trophozoite  and schizont stages. Standard deviation is shown. The antisense  patterns for both genes show a pattern that is inconsistent with a  var silencing role for antisense, with antisense just as high for all  life stages in the active population as in the silenced populations. As  in other genes, adjacent probes for antisense are much more varia- ble than in the corresponding sense strand, suggesting antisense  transcripts are small and interspersed Click here for file Additional data File 4 Agilent 2100 bioanalyzer analysis of total RNA used for  microarrays Agilent 2100 bioanalyzer analysis of total RNA used for microar- rays. Virtual gel images and electrophereograms are shown for all  timepoints for both treatments and replicates Click here for file
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